Cargando…
α-adrenergic agonist brimonidine control of experimentally induced myopia in guinea pigs: A pilot study
PURPOSE: To investigate the efficacy of α-adrenergic agonist brimonidine either alone or combined with pirenzepine for inhibiting progressing myopia in guinea pig lens–myopia-induced models. METHODS: Thirty-six guinea pigs were randomly divided into six groups: Group A received 2% pirenzepine, Group...
Autores principales: | Liu, Yan, Wang, Yuexin, Lv, Huibin, Jiang, Xiaodan, Zhang, Mingzhou, Li, Xuemin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693025/ https://www.ncbi.nlm.nih.gov/pubmed/29204068 |
Ejemplares similares
-
Intravitreal brimonidine inhibits form-deprivation myopia in guinea pigs
por: Yang, Yifang, et al.
Publicado: (2021) -
Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection
por: Nizari, Shereen, et al.
Publicado: (2016) -
Clinical outcomes following trifocal diffractive intraocular lens implantation for age-related cataract in China
por: Yang, Yang, et al.
Publicado: (2018) -
Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity
por: Jiang, Xiaodan, et al.
Publicado: (2018) -
An α2-Adrenergic Agonist, Brimonidine, Beneficially Affects the TGF-β2-Treated Cellular Properties in an In Vitro Culture Model
por: Watanabe, Megumi, et al.
Publicado: (2022)